BACKGROUND: Terminal sedation in patients nearing death is an important
issue related to end-of-life care. OBJECTIVE: To describe the practice of
terminal sedation in the Netherlands. DESIGN: Face-to-face interviews.
SETTING: The Netherlands. PARTICIPANTS: Nationwide stratified sample of
482 physicians; 410 responded and 211 of these reported characteristics of
their most recent terminal sedation case. MEASUREMENTS: Physician reports
of frequency of terminal sedation (defined as the administration of drugs
to keep the patient in deep sedation or coma until death, without giving
artificial nutrition or hydration), characteristics of the decision-making
process, drugs used, the estimated life-shortening effect, and frequency
of euthanasia discussions. RESULTS: Of respondents, 52% (95% CI, 48% to
57%) had ever used terminal sedation. Of the 211 most recent cases,
physicians used terminal sedation to alleviate severe pain in 51% of
patients (CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and dyspnea
in 38% (CI, 32% to 45%). Physicians reported discussing with patients th